IP Library Granted Patent US 7,579,338
Granted Patent B2
US 7,579,338 · App. 11/465,054 · Granted Aug 25, 2009

Methods and compositions for treating atheroma, tumors and other neoplastic tissues

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,579,338
App. No.
11/465,054
Granted
Aug 25, 2009
Kind
B2
Abstract

The radiation sensitization potential of a candidate compound can be screened by determine its ability to generate one or more reactive oxygen species under appropriate conditions. Compounds determined to have radiation sensitization potential are employed in methods for treating atheroma, tumors and other neoplastic tissue as well as other conditions that typically responsive to radiation sensitization.

Claims (6)

1. An injectable formulation comprising motexafin gadolinium, acetic acid, and water, wherein the injectable formulation is pharmaceutically acceptable and stored in a sealed container.

2. The injectable formulation of claim 1 , further comprising a suitable excipient selected from lactose, dextrose, sucrose, sorbitol, mannitol, and syrup.

3. The injectable formulation of any of claims 1 to 2 , wherein the injectable formulation has a pH of about 5.4.

4. The injectable formulation of claim 3 , wherein the sealed container comprises a glass vial.

5. The injectable formulation of claim 4 , wherein the sealed container comprises a head space that has been purged with a gas to exclude oxygen.

6. The injectable formulation of claim 5 , wherein the gas comprises nitrogen gas.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2017
From: PHARMACYCLICS LLC
To: UNIVERSITY OF TEXAS
Reel/Frame 042927/0596 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA PREVIOUSLY RECORDED ON REEL 036126 FRAME 0377. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded May 17, 2016
From: OXFORD AMHERST CORPORATION; PHARMACYCLICS, INC.
To: PHARMACYCLICS, INC.
Reel/Frame 038722/0776 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA PREVIOUSLY RECORDED ON REEL 036126 FRAME 0398. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER AND CHANGE OF NAME. Recorded May 17, 2016
From: PHARMACYCLICS, INC.; OXFORD AMHERST LLC
To: PHARMACYCLICS LLC
Reel/Frame 038722/0849 →
MERGER Recorded Jul 16, 2015
From: OXFORD AMHERST CORPORATION
To: PHARMACYCLICS, INC.
Reel/Frame 036126/0377 →
MERGER AND CHANGE OF NAME Recorded Jul 16, 2015
From: PHARMACYCLICS, INC.; OXFORD AMHERST LLC
To: PHARMACYCLICS LLC
Reel/Frame 036126/0398 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2006
From: MADGA, DARREN
To: PHARMACYCLICS, INC.
Reel/Frame 018225/0127 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2006
From: SESSLER, JONATHAN L.
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, THE
Reel/Frame 018225/0838 →